UCLA expert suggests measures for reducing risk of getting sick during...
It's that time of year when families jet off to all parts of the country – and the globe-;to share some holiday cheer. Unfortunately, all that travel forces people into often-crowded airplanes,...
View ArticleBrief elevation of airborne particulate matter linked to respiratory...
Even the briefest increase in airborne fine particulate matter PM2.5, pollution-causing particles that are about 3 percent of the diameter of human hair, is associated with the development of acute...
View ArticleScientists use cryo-ET techniques to capture images of measles viruses
Researchers have been able to capture images of measles viruses as they emerge from infected cells, using state of the art cryo-electron tomography techniques
View ArticlePfizer starts Phase 1/2 study of RSV vaccine candidate in healthy adult...
Pfizer Inc. today announced that it has started a Phase 1/2 trial of its respiratory syncytial virus (RSV) vaccine candidate in healthy adult volunteers. RSV is a common respiratory virus that affects...
View ArticleNIAID launches clinical trial of investigational RSV vaccine
The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, has launched a clinical trial of an investigational vaccine designed to protect against respiratory...
View ArticleVanderbilt researchers isolate antibody that can neutralize West Nile virus
Researchers at Vanderbilt University Medical Center and colleagues have isolated a human monoclonal antibody that can "neutralize" the West Nile virus and potentially prevent a leading cause of viral...
View ArticleDuke-NUS researchers highlight possible role of bioaerosol sampling in...
As a leading global city with a high population density, Singapore is vulnerable to the introduction of biological threats. Initiating an early emergency response to such threats calls for the rapid...
View ArticleHouston Methodist launches real-time website to track flu cases
Pathologists at Houston Methodist developed a real-time website to track flu cases, just in time to assist physicians, the CDC and patients for the fall 2018 flu season.
View ArticleA promising, effective vaccine for common respiratory disease
Skin vaccination using a microneedle patch that contains the inactivated respiratory syncytial virus (RSV) and a compound that stimulates immune responses to the virus has been found to enhance...
View ArticleQuidel receives CE mark to use Sofia 2 Lyme+ Fluorescent Immunoassay with...
Quidel Corporation, a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that it has received CE Mark to market Quidel's...
View ArticleInfants with bronchiolitis are at increased risk of hospitalization for...
Infants who are admitted to hospital with the common infection bronchiolitis are at increased risk of further emergency hospital admissions for asthma, wheezing and respiratory illness in the first...
View ArticleThe antiviral potential of 4′-fluorouridine as an oral treatment against RSV...
New research reports 4’-Fluorouridine (4′-FlU) as an oral antiviral against RSV and SARS-CoV-2.
View ArticleVaccines and monoclonal antibodies being developed for respiratory syncytial...
A new study reviews recent advancements made in the development of RSV immunoprophylactic measures.
View ArticleThe maternal RSV vaccine from Pfizer protects newborns against severe illness
Pfizer announced its maternal vaccine against RSV to be almost 82% effective in protecting infants for the first 90 days of life against severe illness.
View ArticleRSV and kids: What you need to know
An overview on the prevalence, symptoms, and management of RSV in children.
View ArticleSurge in RSV cases – how worried should you be?
RSV hospitalizations are reaching similarly high levels much earlier than normal this year.
View ArticleResearchers identify a novel RSV variant associated with prolonged infection
Researchers examine pathogen or host genetic risk factors for RSV infection, as well as whether certain viral variants are associated with prolonged infection.
View ArticlePreparing for epidemics now and in the future
The World Health Organization (WHO) recently conducted a virtual press conference on global health emergencies on November 16, 2022. Margaret Harris hosted the conference at WHO Headquarters in Geneva....
View ArticleAre nasal-spray vaccines the solution to respiratory infectious diseases?
A recent study published in the journal Trends in Molecular Medicine reviewed the current efforts in developing nasal vaccines, delivery systems, and clinical applications for preventing respiratory...
View ArticleRSV causes 160,000 hospitalizations every year in the EU, according to new study
Researchers estimate hospitalizations associated with respiratory syncytial virus infection in the European Union.
View Article